Vimarsana
Biggest News Aggregation in the World

Cornell Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cornell Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cornell Scale Today - Breaking & Trending Today

Phototherapy May Aid Cognitive Function With Dementia - Vimarsana News

Phototherapy May Aid Cognitive Function With Dementia

Phototherapy may improve cognitive function in patients with dementia, according to a systematic review and meta-analysis.

Phototherapy May Aid Cognitive Function With Dementia - Vimarsana News

Phototherapy May Aid Cognitive Function With Dementia

Phototherapy may improve cognitive function in patients with dementia.

Phototherapy a Safe, Effective New Option for Dementia? - Vimarsana News

Phototherapy a Safe, Effective New Option for Dementia?

Phototherapy is a safe, effective, noninvasive, inexpensive way of boosting cognition in dementia in new research that suggests it may be "one of the most promising" interventions for improving core symptoms of the disease.

Phototherapy May Aid Cognitive Function With Dementia - Vimarsana News

Phototherapy May Aid Cognitive Function With Dementia

FRIDAY, April 7, 2023 (HealthDay News) -- Phototherapy may improve cognitive function in patients with dementia, according to a systematic review and meta-analysis published online April 5 in Brain and

Axsome Therapeutics, Inc. Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation - Vimarsana News

Axsome Therapeutics, Inc. Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation

Axsome Therapeutics, Inc. announced that AXS-05, a novel, oral, investigational NMDA receptor antagonist with multimodal activity, met the primary and key secondary endpoints in the ACCORD Phase 3... | November 29, 2022